Yuanyuan Du

3.5k total citations
54 papers, 2.1k citations indexed

About

Yuanyuan Du is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yuanyuan Du has authored 54 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Yuanyuan Du's work include Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Yuanyuan Du is often cited by papers focused on Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Yuanyuan Du collaborates with scholars based in China, Australia and Singapore. Yuanyuan Du's co-authors include Hongkui Deng, Jun Xu, Xiangjian Zhang, Hui Ji, Litao Li, Shuya Li, Haichao Liu, Yang Zhao, Yan Shi and Haichao Liu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuanyuan Du

50 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanyuan Du China 20 1.5k 322 256 214 175 54 2.1k
Yuh-Lih Chang Taiwan 29 1.4k 0.9× 299 0.9× 169 0.7× 126 0.6× 462 2.6× 56 2.5k
Lei Guo China 23 958 0.6× 180 0.6× 76 0.3× 244 1.1× 241 1.4× 82 2.1k
Whaseon Lee‐Kwon United States 28 1.6k 1.1× 228 0.7× 72 0.3× 195 0.9× 251 1.4× 56 2.5k
Jianhong Zhu China 30 1.4k 0.9× 176 0.5× 180 0.7× 261 1.2× 368 2.1× 78 2.5k
Mariarosaria Miloso Italy 26 883 0.6× 234 0.7× 156 0.6× 220 1.0× 184 1.1× 55 2.0k
Claudia Nesti Italy 25 995 0.6× 181 0.6× 100 0.4× 263 1.2× 109 0.6× 82 1.9k
Aijun Sun China 34 1.6k 1.1× 634 2.0× 168 0.7× 65 0.3× 396 2.3× 115 3.4k
Xuebin Qu China 22 701 0.5× 282 0.9× 81 0.3× 76 0.4× 341 1.9× 32 1.5k
Tian‐Ying Xu China 23 806 0.5× 158 0.5× 104 0.4× 115 0.5× 116 0.7× 35 1.9k
Shuyu Ren United States 26 1.7k 1.1× 270 0.8× 54 0.2× 131 0.6× 560 3.2× 38 3.0k

Countries citing papers authored by Yuanyuan Du

Since Specialization
Citations

This map shows the geographic impact of Yuanyuan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Du more than expected).

Fields of papers citing papers by Yuanyuan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Du. The network helps show where Yuanyuan Du may publish in the future.

Co-authorship network of co-authors of Yuanyuan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyuan Du. A scholar is included among the top collaborators of Yuanyuan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyuan Du. Yuanyuan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Łozińska, Magdalena M., Elliott L. Bruce, Manoranjan Kumar Manoj, et al.. (2025). In Situ Generation by Cyclization of an Organic Structure Directing Agent for the Synthesis of High Silica Zeolite ERS‐7. Chemistry - A European Journal. 31(30). e202500327–e202500327. 1 indexed citations
2.
Du, Yuanyuan, Mimi Xu, Li Wan, et al.. (2025). Expansion of peripheral helper T cells in the peripheral blood of patients with chronic graft-versus-host disease. Annals of Hematology. 104(10). 5343–5358.
3.
4.
Liu, Xiaohui, Wen-Biao Han, Liqin Gao, et al.. (2024). Comparative safety and efficacy of percutaneous radiofrequency thermocoagulation and percutaneous balloon compression in CT-guided and local anesthesia for recurrent trigeminal neuralgia. Frontiers in Neurology. 14. 1336261–1336261. 2 indexed citations
5.
Chen, Linyu, Yuanyuan Du, Huimin Qiao, et al.. (2023). Proprotein convertase subtilisin/kexin type 9 inhibitor ameliorates cerebral ischemia in mice by inhibiting inflammation. Journal of Stroke and Cerebrovascular Diseases. 33(2). 107517–107517. 8 indexed citations
6.
Yang, Wenjun, Yaqi Wang, Yuanyuan Du, et al.. (2023). Chemical reprogramming of melanocytes to skeletal muscle cells. Journal of Cachexia Sarcopenia and Muscle. 14(2). 903–914. 4 indexed citations
7.
Hu, Bo, Li Wan, Ziqi Jin, et al.. (2022). IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity. Experimental Hematology and Oncology. 11(1). 34–34. 7 indexed citations
8.
Wu, Fei, et al.. (2022). A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden. BMC Oral Health. 22(1). 152–152. 15 indexed citations
9.
Zhang, Yanyan, Shuyi Zhu, Yuanyuan Du, et al.. (2022). RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion. Journal of Experimental & Clinical Cancer Research. 41(1). 66–66. 27 indexed citations
10.
Du, Yuanyuan, et al.. (2021). Lactate is Associated with Increased 30-Day Mortality in Critically Ill Patients with Alcohol Use Disorder. International Journal of General Medicine. Volume 14. 2741–2749. 3 indexed citations
11.
Guo, Lingyun, Zhenjiang Wang, Yuanyuan Du, et al.. (2020). Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma. Cancer Cell International. 20(1). 251–251. 39 indexed citations
12.
Xue, Jiang, et al.. (2020). Bioinformatics analysis reveals novel hub gene pathways associated with IgA nephropathy. European journal of medical research. 25(1). 40–40. 4 indexed citations
13.
Du, Yuanyuan, et al.. (2019). Jixuecao (Herba Centellae Asiaticae) alleviates mesangial cell proliferation in IgA nephropathy by inducing mitofusin 2 expression.. PubMed. 39(3). 346–355. 3 indexed citations
14.
Zhu, Bin, Jicheng Lv, Yi Lin, et al.. (2018). Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases. American Journal of Nephrology. 48(2). 127–136. 21 indexed citations
15.
Ni, Jie, Leilei Zhou, Li Ding, et al.. (2017). PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway. Experimental Cell Research. 361(2). 246–256. 31 indexed citations
16.
Xu, Jun, Yuanyuan Du, & Hongkui Deng. (2015). Direct Lineage Reprogramming: Strategies, Mechanisms, and Applications. Cell stem cell. 16(2). 119–134. 318 indexed citations
17.
Li, Xiang, Junzhan Jing, Jiaming Wang, et al.. (2015). Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons. Cell stem cell. 17(2). 195–203. 324 indexed citations
18.
Li, Shuya, Xiangjian Zhang, Yongjun Wang, et al.. (2012). DAPT protects brain against cerebral ischemia by down-regulating the expression of Notch 1 and Nuclear factor kappa B in rats. Neurological Sciences. 33(6). 1257–1264. 34 indexed citations
19.
Du, Yuanyuan, Xiangjian Zhang, Hui Ji, et al.. (2012). Probucol and atorvastatin in combination protect rat brains in MCAO model: Upregulating Peroxiredoxin2, Foxo3a and Nrf2 expression. Neuroscience Letters. 509(2). 110–115. 42 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuh-Lih Chang Breakdown of academic impact, for papers by Lei Guo Breakdown of academic impact, for papers by Whaseon Lee‐Kwon Breakdown of academic impact, for papers by Jianhong Zhu Breakdown of academic impact, for papers by Mariarosaria Miloso Breakdown of academic impact, for papers by Claudia Nesti Breakdown of academic impact, for papers by Aijun Sun Breakdown of academic impact, for papers by Xuebin Qu Breakdown of academic impact, for papers by Tian‐Ying Xu Breakdown of academic impact, for papers by Shuyu Ren
Rankless by CCL
2026